GT Shareholder Can Cui will speak at a roundtable on “Building a Global Ophthalmic Innovation Ecosystem: Accelerating Lab to Market Transitions through Sino-Foreign Cooperation,” and will be joined by ophthalmology industry and academic leaders in China, from China Eye Valley, Hefei Starchaser Biopharmaceuticals, Chengdu WestChina-Frontier PharmaTech, Suzhou Innostellar Biotherapeutics, and Wenzhou Medical University School of Ophthalmology & Optometry.
The conference will convene leading researchers, industry executives, regulatory authorities, and investors from around the globe to engage in substantive discussions on emerging technologies, unmet medical needs, international market dynamics, and pathways to innovation.